CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: carboxylic acid dianion
Accession: CHEBI:38716
browse the term
Definition: Any dianion containing at least one carboxy group.
Synonyms: related_synonym: carboxylic acid dianions
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
SIRT1 protein inhibits the reaction [Calcium Oxalate results in increased expression of BAX protein]
CTD
PMID:34333021
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO
SIRT1 protein inhibits the reaction [Calcium Oxalate results in decreased expression of BCL2 protein]
CTD
PMID:34333021
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions increases cleavage
ISO
SIRT1 protein inhibits the reaction [Calcium Oxalate results in increased cleavage of CASP3 protein]
CTD
PMID:34333021
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions decreases expression
EXP
2-aminoethyl diphenylborinate inhibits the reaction [Calcium Oxalate results in decreased expression of CAT protein]
CTD
PMID:37454925
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
decreases expression multiple interactions
EXP
Calcium Oxalate results in decreased expression of CCL2 protein 2-aminoethyl diphenylborinate inhibits the reaction [Calcium Oxalate results in decreased expression of CCL2 protein]; [Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CCL2 mRNA; [Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CCL2 protein; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CCL2 mRNA]; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CCL2 protein]
CTD
PMID:37414240 PMID:37454925
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cd44
CD44 molecule
multiple interactions decreases expression
EXP
2-aminoethyl diphenylborinate inhibits the reaction [Calcium Oxalate results in decreased expression of CD44 protein]; [Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CD44 mRNA; [Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CD44 protein; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CD44 mRNA]; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CD44 protein]
CTD
PMID:37414240 PMID:37454925
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cybb
cytochrome b-245 beta chain
multiple interactions increases expression
EXP
2-aminoethyl diphenylborinate inhibits the reaction [Calcium Oxalate results in increased expression of NOX2 protein]
CTD
PMID:37454925
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp2c7
cytochrome P450, family 2, subfamily c, polypeptide 7
multiple interactions
EXP
[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CYP2C9 mRNA; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CYP2C9 mRNA]
CTD
PMID:37414240
NCBI chr 1:237,332,641...237,388,714
Ensembl chr 1:237,332,659...237,388,709
G
Hdac1
histone deacetylase 1
multiple interactions
EXP
[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC1 mRNA; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC1 mRNA]
CTD
PMID:37414240
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
G
Hdac2
histone deacetylase 2
multiple interactions
EXP
[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC2 mRNA; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC2 mRNA]
CTD
PMID:37414240
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Hdac3
histone deacetylase 3
multiple interactions
EXP
[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC3 mRNA; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC3 mRNA]
CTD
PMID:37414240
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
G
Hdac8
histone deacetylase 8
multiple interactions
EXP
[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC8 mRNA; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC8 mRNA]
CTD
PMID:37414240
NCBI chr X:67,385,288...67,593,014
Ensembl chr X:67,385,289...67,592,923
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
phenyl-N-tert-butylnitrone inhibits the reaction [Calcium Oxalate results in increased expression of HMOX1 protein]
CTD
PMID:34333021
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
increases expression multiple interactions
EXP
Calcium Oxalate results in increased expression of ITPR1 protein Losartan inhibits the reaction [Calcium Oxalate results in increased expression of ITPR1 protein]
CTD
PMID:37454925
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
multiple interactions increases expression
EXP
Losartan inhibits the reaction [Calcium Oxalate results in increased expression of ITPR2 protein]
CTD
PMID:37454925
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
increases expression
EXP
Calcium Oxalate results in increased expression of ITPR3 protein
CTD
PMID:37454925
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
G
Nox4
NADPH oxidase 4
increases expression multiple interactions
EXP
Calcium Oxalate results in increased expression of NOX4 protein 2-aminoethyl diphenylborinate inhibits the reaction [Calcium Oxalate results in increased expression of NOX4 protein]
CTD
PMID:37454925
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Sirt1
sirtuin 1
multiple interactions decreases expression
ISO
phenyl-N-tert-butylnitrone inhibits the reaction [Calcium Oxalate results in decreased expression of SIRT1 protein]; SIRT1 protein inhibits the reaction [Calcium Oxalate results in decreased expression of BCL2 protein]; SIRT1 protein inhibits the reaction [Calcium Oxalate results in increased cleavage of CASP3 protein]; SIRT1 protein inhibits the reaction [Calcium Oxalate results in increased expression of BAX protein]
CTD
PMID:34333021
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sod1
superoxide dismutase 1
multiple interactions decreases expression
EXP
2-aminoethyl diphenylborinate inhibits the reaction [Calcium Oxalate results in decreased expression of SOD1 protein]
CTD
PMID:37454925
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Spp1
secreted phosphoprotein 1
multiple interactions decreases expression
EXP
2-aminoethyl diphenylborinate inhibits the reaction [Calcium Oxalate results in decreased expression of SPP1 protein]; [Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of SPP1 mRNA; [Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of SPP1 protein; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of SPP1 mRNA]; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of SPP1 protein]
CTD
PMID:37414240 PMID:37454925
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression
ISO
Carboplatin results in decreased expression of ABCB1 mRNA; Carboplatin results in decreased expression of ABCB1 protein
CTD
PMID:27692344
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb4
ATP binding cassette subfamily B member 4
decreases expression
EXP
Carboplatin results in decreased expression of ABCB4 mRNA
CTD
PMID:18172885
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc1
ATP binding cassette subfamily C member 1
decreases expression
ISO
Carboplatin results in decreased expression of ABCC1 mRNA; Carboplatin results in decreased expression of ABCC1 protein
CTD
PMID:27692344
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression
ISO
Carboplatin results in decreased expression of ABCC2 mRNA; Carboplatin results in decreased expression of ABCC2 protein
CTD
PMID:27692344
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcg2
ATP binding cassette subfamily G member 2
decreases expression
ISO
Carboplatin results in decreased expression of ABCG2 mRNA; Carboplatin results in decreased expression of ABCG2 protein
CTD
PMID:27692344
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Acvr1c
activin A receptor type 1C
increases response to substance
ISO
ACVR1C results in increased susceptibility to Carboplatin
CTD
PMID:21224400
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
G
Ahr
aryl hydrocarbon receptor
decreases expression
ISO
Carboplatin results in decreased expression of AHR mRNA
CTD
PMID:36536508
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
EXP
Carboplatin results in increased expression of AKR1B1 mRNA
CTD
PMID:18172885
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased phosphorylation of AKT1 protein]; Carboplatin promotes the reaction [Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased phosphorylation of AKT1 protein]]; Pravastatin inhibits the reaction [Carboplatin results in increased activity of and results in increased phosphorylation of AKT1 protein]; Pulsatilla saponin A promotes the reaction [Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased phosphorylation of AKT1 protein]]
CTD
PMID:18483861 PMID:33190582
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alas2
5'-aminolevulinate synthase 2
decreases expression
EXP
Carboplatin results in decreased expression of ALAS2 mRNA
CTD
PMID:21296123
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
affects response to substance
ISO
ALDH1A1 protein affects the susceptibility to Carboplatin
CTD
PMID:18854779
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
affects response to substance
ISO
ALDH3A1 protein affects the susceptibility to Carboplatin
CTD
PMID:18854779
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Anxa4
annexin A4
decreases response to substance affects localization multiple interactions
ISO
ANXA4 protein results in decreased susceptibility to Carboplatin Carboplatin affects the localization of ANXA4 protein ATP7A protein promotes the reaction [ANXA4 protein results in decreased susceptibility to Carboplatin]
CTD
PMID:24150977
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Arfgef1
ARF guanine nucleotide exchange factor 1
increases response to substance
ISO
ARFGEF1 results in increased susceptibility to Carboplatin
CTD
PMID:21755009
NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326
G
Arl4c
ARF like GTPase 4C
affects response to substance
ISO
ARL4C protein affects the susceptibility to Carboplatin
CTD
PMID:36366750
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
decreases expression
EXP
Carboplatin results in decreased expression of ATP1A1 mRNA
CTD
PMID:18172885
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Atp7a
ATPase copper transporting alpha
affects localization multiple interactions
ISO
Carboplatin affects the localization of ATP7A protein [MIR495 mRNA results in decreased expression of ATP7A protein] which results in increased susceptibility to Carboplatin; ATP7A protein promotes the reaction [ANXA4 protein results in decreased susceptibility to Carboplatin]
CTD
PMID:24038379 PMID:24150977
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Atp7b
ATPase copper transporting beta
multiple interactions
ISO
ATP7B protein binds to and results in increased metabolism of Carboplatin
CTD
PMID:23751120
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression increases expression multiple interactions
ISO
Carboplatin results in decreased expression of BAX mRNA Carboplatin results in increased expression of BAX mRNA; Carboplatin results in increased expression of BAX protein [Carboplatin co-treated with Gallic Acid] results in increased expression of BAX protein; [Gallic Acid co-treated with Carboplatin] results in increased expression of BAX mRNA; [Paclitaxel co-treated with Carboplatin co-treated with Gallic Acid] results in increased expression of BAX mRNA; [Paclitaxel co-treated with Carboplatin co-treated with Gallic Acid] results in increased expression of BAX protein; [Paclitaxel co-treated with Carboplatin] results in increased expression of BAX mRNA; [Paclitaxel co-treated with Carboplatin] results in increased expression of BAX protein; Carboplatin results in increased cleavage of and results in increased expression of BAX protein
CTD
PMID:15131059 PMID:15576332 PMID:33002289
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Carboplatin results in decreased expression of BCL2 mRNA; Carboplatin results in decreased expression of BCL2 protein
CTD
PMID:9664115 PMID:15576332 PMID:15996812 PMID:17404015
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression multiple interactions
ISO EXP
Carboplatin results in decreased expression of BCL2L1 protein Acetylcysteine inhibits the reaction [Carboplatin results in decreased expression of BCL2L1 protein]
CTD
PMID:18483861
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl2l12
Bcl2 like 12
increases expression
ISO
Carboplatin results in increased expression of BCL2L12 mRNA
CTD
PMID:15576332
NCBI chr 1:95,472,272...95,480,991
Ensembl chr 1:95,472,272...95,480,991
G
Becn1
beclin 1
decreases expression multiple interactions
ISO
Carboplatin results in decreased expression of BECN1 protein Carboplatin promotes the reaction [Chloroquine results in decreased expression of BECN1 protein]; Chloroquine promotes the reaction [Carboplatin results in decreased expression of BECN1 protein]
CTD
PMID:27692344
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Birc2
baculoviral IAP repeat-containing 2
decreases response to substance
ISO
BIRC2 protein results in decreased susceptibility to Carboplatin
CTD
PMID:10815900
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Blmh
bleomycin hydrolase
decreases expression
EXP
Carboplatin results in decreased expression of BLMH mRNA
CTD
PMID:18172885
NCBI chr10:61,772,112...61,815,212
Ensembl chr10:61,758,478...61,815,212
G
Brca1
BRCA1, DNA repair associated
decreases activity
ISO
Carboplatin results in decreased activity of BRCA1 protein
CTD
PMID:20878461
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Camkk2
calcium/calmodulin-dependent protein kinase kinase 2
affects response to substance
ISO
CAMKK2 protein affects the susceptibility to Carboplatin
CTD
PMID:28634229
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
G
Canx
calnexin
decreases expression
EXP
Carboplatin results in decreased expression of CANX mRNA
CTD
PMID:18172885
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
G
Casp2
caspase 2
decreases expression
EXP
Carboplatin results in decreased expression of CASP2 mRNA
CTD
PMID:18172885
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
G
Casp3
caspase 3
multiple interactions increases activity increases expression
ISO EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Carboplatin results in increased cleavage of and results in increased activity of CASP3 protein]; [Carboplatin co-treated with Gallic Acid] results in increased expression of CASP3 protein; [Gallic Acid co-treated with Carboplatin] results in increased expression of CASP3 mRNA; [Paclitaxel co-treated with Carboplatin co-treated with Gallic Acid] results in increased expression of CASP3 mRNA; [Paclitaxel co-treated with Carboplatin co-treated with Gallic Acid] results in increased expression of CASP3 protein; [Paclitaxel co-treated with Carboplatin] results in increased expression of CASP3 mRNA; [Paclitaxel co-treated with Carboplatin] results in increased expression of CASP3 protein; Carboplatin results in increased cleavage of and results in increased activity of CASP3 protein; palbociclib inhibits the reaction [Carboplatin results in increased activity of CASP3 protein] Carboplatin results in increased expression of CASP3 protein Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP3 protein]; Pravastatin inhibits the reaction [Carboplatin results in increased expression of CASP3 protein] [Carboplatin co-treated with 1,2-Dimethylhydrazine] results in increased expression of CASP3 protein; Carboplatin promotes the reaction [[Pulsatilla saponin A co-treated with 1,2-Dimethylhydrazine] results in increased expression of CASP3 protein]; Pravastatin inhibits the reaction [Carboplatin results in increased expression of CASP3 protein]; Pulsatilla saponin A promotes the reaction [[Carboplatin co-treated with 1,2-Dimethylhydrazine] results in increased expression of CASP3 protein] Carboplatin results in increased expression of CASP3 mRNA; Carboplatin results in increased expression of CASP3 protein
CTD
PMID:15576332 PMID:16275998 PMID:18483861 PMID:20368269 PMID:22302033 PMID:33002289 PMID:33190582 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases activity multiple interactions
ISO
Carboplatin results in increased activity of CASP7 protein palbociclib inhibits the reaction [Carboplatin results in increased activity of CASP7 protein]
CTD
PMID:22302033
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
increases activity decreases expression multiple interactions increases expression
ISO EXP
Carboplatin results in increased activity of CASP9 protein Carboplatin results in decreased expression of CASP9 mRNA Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP9 protein]; Pravastatin inhibits the reaction [Carboplatin results in increased expression of CASP9 protein]
CTD
PMID:15576332 PMID:15996812 PMID:17404015 PMID:18483861
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
decreases activity decreases expression multiple interactions
EXP
Carboplatin results in decreased activity of CAT protein Carboplatin results in decreased expression of CAT protein Carboplatin results in decreased expression of and results in decreased activity of CAT protein
CTD
PMID:11124453 PMID:15109710 PMID:15225673
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccnd1
cyclin D1
multiple interactions
ISO
Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CCND1 protein]; Carboplatin promotes the reaction [Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CCND1 protein]]; Pulsatilla saponin A promotes the reaction [Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CCND1 protein]]
CTD
PMID:33190582
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cd274
CD274 molecule
decreases expression
ISO
Carboplatin results in decreased expression of CD274; Carboplatin results in decreased expression of CD274 protein
CTD
PMID:21765211 PMID:27692344
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd44
CD44 molecule
decreases expression
EXP
Carboplatin results in decreased expression of CD44 mRNA
CTD
PMID:18172885
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cdc25b
cell division cycle 25B
decreases expression
EXP
Carboplatin results in decreased expression of CDC25B mRNA
CTD
PMID:21296123
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
G
Cdc42
cell division cycle 42
decreases expression
EXP
Carboplatin results in decreased expression of CDC42 mRNA
CTD
PMID:18172885
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO EXP
Carboplatin results in increased expression of CDKN1A protein Carboplatin results in increased expression of CDKN1A mRNA
CTD
PMID:9664115 PMID:18172885
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
EXP
Carboplatin results in increased expression of CITED2 mRNA
CTD
PMID:18172885
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Clu
clusterin
decreases expression
EXP
Carboplatin results in decreased expression of CLU mRNA
CTD
PMID:18172885
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cops5
COP9 signalosome subunit 5
increases response to substance
ISO
COPS5 results in increased susceptibility to Carboplatin
CTD
PMID:21755009
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
G
Cycs
cytochrome c, somatic
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CYCS protein]; Pravastatin inhibits the reaction [Carboplatin results in increased expression of CYCS protein]
CTD
PMID:18483861
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Dct
dopachrome tautomerase
decreases response to substance
ISO
DCT protein results in decreased susceptibility to Carboplatin
CTD
PMID:15897911
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
G
Ddit3
DNA-damage inducible transcript 3
increases expression
EXP
Carboplatin results in increased expression of DDIT3 mRNA
CTD
PMID:18172885
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dpyd
dihydropyrimidine dehydrogenase
multiple interactions
ISO
PCNA mRNA affects the reaction [DPYD mRNA affects the susceptibility to Carboplatin]
CTD
PMID:16685392
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
affects phosphorylation
ISO
Carboplatin affects the phosphorylation of EIF2S1 protein
CTD
PMID:29053414
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Epcam
epithelial cell adhesion molecule
multiple interactions
ISO
[Paclitaxel co-treated with Carboplatin] results in increased expression of EPCAM protein
CTD
PMID:12695858
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Epo
erythropoietin
increases expression
EXP
Carboplatin results in increased expression of EPO protein
CTD
PMID:17891399
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Erbb2
erb-b2 receptor tyrosine kinase 2
multiple interactions
ISO
ERBB2 protein results in decreased susceptibility to [Cyclophosphamide co-treated with Thiotepa co-treated with Carboplatin]
CTD
PMID:16446318
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Fas
Fas cell surface death receptor
increases expression
ISO
Carboplatin results in increased expression of FAS mRNA
CTD
PMID:15576332
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fshb
follicle stimulating hormone subunit beta
increases expression
EXP
Carboplatin results in increased expression of FSHB protein
CTD
PMID:8776818
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Gsr
glutathione-disulfide reductase
decreases activity
EXP
Carboplatin results in decreased activity of GSR protein
CTD
PMID:11124453
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gstp1
glutathione S-transferase pi 1
affects response to substance
ISO
GSTP1 gene affects the susceptibility to Carboplatin
CTD
PMID:12360105
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
H2ax
H2A.X variant histone
increases expression increases phosphorylation multiple interactions
ISO
Carboplatin results in increased expression of H2AX protein Carboplatin results in increased phosphorylation of H2AX protein palbociclib inhibits the reaction [Carboplatin results in increased expression of H2AX protein]; phellopterin promotes the reaction [[Carboplatin results in increased phosphorylation of H2AX protein] which results in increased susceptibility to Carboplatin]; phellopterin promotes the reaction [Carboplatin results in increased phosphorylation of H2AX protein]
CTD
PMID:22302033 PMID:37708916
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Hax1
HCLS1 associated protein X-1
multiple interactions
EXP
Pravastatin inhibits the reaction [Carboplatin results in decreased expression of HAX1 protein]
CTD
PMID:18483861
NCBI chr 2:175,434,242...175,437,926
Ensembl chr 2:175,434,238...175,437,714
G
Hbb
hemoglobin subunit beta
decreases expression
EXP
Carboplatin results in decreased expression of HBB mRNA
CTD
PMID:21296123
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
G
Hmox1
heme oxygenase 1
multiple interactions increases expression decreases response to substance decreases expression
ISO EXP
HMOX1 protein inhibits the reaction [Carboplatin results in increased activity of NFATC4] Carboplatin results in increased expression of HMOX1 mRNA HMOX1 protein results in decreased susceptibility to Carboplatin Carboplatin results in decreased expression of HMOX1 mRNA
CTD
PMID:18172885 PMID:20368269 PMID:21198546 PMID:26260164
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
decreases expression
EXP
Carboplatin results in decreased expression of HSD17B4 mRNA
CTD
PMID:18172885
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
EXP
Carboplatin results in increased expression of HSPA1A mRNA
CTD
PMID:18172885
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
EXP
Carboplatin results in increased expression of HSPA1B mRNA
CTD
PMID:18172885
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa5
heat shock protein family A (Hsp70) member 5
decreases expression
EXP
Carboplatin results in decreased expression of HSPA5 mRNA
CTD
PMID:18172885
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspb1
heat shock protein family B (small) member 1
increases expression
EXP
Carboplatin results in increased expression of HSPB1 mRNA
CTD
PMID:18172885
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Igf2r
insulin-like growth factor 2 receptor
decreases expression
EXP
Carboplatin results in decreased expression of IGF2R mRNA
CTD
PMID:18172885
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Il6
interleukin 6
decreases response to substance
ISO
IL6 protein results in decreased susceptibility to Carboplatin
CTD
PMID:7834629
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
decreases response to substance
ISO
IL6R protein results in decreased susceptibility to Carboplatin
CTD
PMID:7834629
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Carboplatin results in decreased expression of JUN mRNA
CTD
PMID:18172885
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Klk1c10
kallikrein 1-related peptidase C10
multiple interactions
ISO
[Paclitaxel co-treated with Carboplatin] results in decreased expression of KLK3 protein
CTD
PMID:16442593
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
decreases expression
EXP
Carboplatin results in decreased expression of MAP3K1 mRNA
CTD
PMID:18172885
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
G
Map3k12
mitogen activated protein kinase kinase kinase 12
decreases expression
EXP
Carboplatin results in decreased expression of MAP3K12 mRNA
CTD
PMID:18172885
NCBI chr 7:133,630,267...133,648,464
Ensembl chr 7:133,630,835...133,640,789
G
Mapk14
mitogen activated protein kinase 14
decreases expression
EXP
Carboplatin results in decreased expression of MAPK14 mRNA
CTD
PMID:18172885
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk6
mitogen-activated protein kinase 6
decreases expression
EXP
Carboplatin results in decreased expression of MAPK6 mRNA
CTD
PMID:18172885
NCBI chr 8:76,146,650...76,169,767
Ensembl chr 8:76,146,690...76,169,720
G
Mgmt
O-6-methylguanine-DNA methyltransferase
decreases expression
EXP
Carboplatin results in decreased expression of MGMT mRNA
CTD
PMID:18172885
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mir155
microRNA 155
multiple interactions
ISO
[Carboplatin co-treated with Chloroquine] results in increased expression of MIR155 mRNA
CTD
PMID:27692344
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Carboplatin promotes the reaction [Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]; Pulsatilla saponin A promotes the reaction [Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]
CTD
PMID:33190582
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mpo
myeloperoxidase
multiple interactions
EXP
[Carboplatin co-treated with Carnitine deficiency] results in increased expression of MPO protein
CTD
PMID:18852009
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Msh2
mutS homolog 2
decreases expression
EXP
Carboplatin results in decreased expression of MSH2 mRNA
CTD
PMID:18172885
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
G
Msh6
mutS homolog 6
affects response to substance
ISO
MSH6 protein affects the susceptibility to Carboplatin
CTD
PMID:39168426
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
G
Mt1
metallothionein 1
decreases expression increases expression
EXP ISO
Carboplatin results in decreased expression of MT1A mRNA Carboplatin results in increased expression of MT1A mRNA
CTD
PMID:18172885 PMID:35027733
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases response to substance
ISO
MYC protein results in increased susceptibility to Carboplatin
CTD
PMID:21324178
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nanog
Nanog homeobox
increases expression
ISO
Carboplatin results in increased expression of NANOG mRNA
CTD
PMID:25605917
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
G
Nbas
NBAS subunit of NRZ tethering complex
affects response to substance
ISO
NBAS intron polymorphism affects the susceptibility to Carboplatin
CTD
PMID:21844884
NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984
G
Nckap1
NCK-associated protein 1
decreases expression
EXP
Carboplatin results in decreased expression of NCKAP1 mRNA
CTD
PMID:18172885
NCBI chr 3:65,417,450...65,491,769
Ensembl chr 3:65,417,453...65,492,217
G
Nfatc4
nuclear factor of activated T-cells 4
multiple interactions increases activity
ISO EXP
HMOX1 protein inhibits the reaction [Carboplatin results in increased activity of NFATC4]
CTD
PMID:21198546
NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions decreases expression
ISO EXP
Carboplatin results in increased activity of [NFKB1 protein binds to NFKB1 protein]; Carboplatin results in increased activity of [NFKB1 protein binds to RELA protein]; NFKBIA gene mutant form inhibits the reaction [Carboplatin results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; NFKBIA gene mutant form inhibits the reaction [Carboplatin results in increased activity of [NFKB1 protein binds to RELA protein]] Carboplatin results in decreased expression of NFKB1 mRNA
CTD
PMID:12675310 PMID:18172885
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
decreases phosphorylation multiple interactions
ISO
Carboplatin results in decreased phosphorylation of NFKBIA protein NFKBIA gene mutant form inhibits the reaction [Carboplatin results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; NFKBIA gene mutant form inhibits the reaction [Carboplatin results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:12675310 PMID:15120608
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nodal
nodal growth differentiation factor
increases response to substance
ISO
NODAL results in increased susceptibility to Carboplatin
CTD
PMID:21224400
NCBI chr20:29,368,436...29,376,837
Ensembl chr20:29,368,436...29,376,837
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Carboplatin results in increased expression of NQO1 mRNA
CTD
PMID:18172885
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nras
NRAS proto-oncogene, GTPase
decreases expression
EXP
Carboplatin results in decreased expression of NRAS mRNA
CTD
PMID:18172885
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Or4d6
olfactory receptor family 4 subfamily D member 6
affects response to substance
ISO
OR4D6 gene SNP affects the susceptibility to Carboplatin
CTD
PMID:26378035
NCBI chr 1:209,039,073...209,040,017
Ensembl chr 1:209,037,992...209,045,985
G
Osm
oncostatin M
increases expression
ISO
Carboplatin results in increased expression of OSM mRNA
CTD
PMID:36536508
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Carboplatin results in increased cleavage of PARP1 protein
CTD
PMID:15996812
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
decreases expression
EXP
Carboplatin results in decreased expression of PAWR mRNA
CTD
PMID:18172885
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pcna
proliferating cell nuclear antigen
multiple interactions increases expression
ISO EXP
PCNA mRNA affects the reaction [DPYD mRNA affects the susceptibility to Carboplatin]; PCNA mRNA affects the reaction [TYMS mRNA affects the susceptibility to Carboplatin] Carboplatin results in increased expression of PCNA mRNA
CTD
PMID:16685392 PMID:18172885
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pdcd1lg2
programmed cell death 1 ligand 2
decreases expression multiple interactions
ISO
Carboplatin results in decreased expression of PDCD1LG2 STAT6 gene mutant form inhibits the reaction [Carboplatin results in decreased expression of PDCD1LG2]
CTD
PMID:21765211
NCBI chr 1:227,158,941...227,223,938
Ensembl chr 1:227,158,941...227,223,938
G
Pdia4
protein disulfide isomerase family A, member 4
decreases expression
EXP
Carboplatin results in decreased expression of PDIA4 mRNA
CTD
PMID:18172885
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pdia6
protein disulfide isomerase family A, member 6
decreases expression
EXP
Carboplatin results in decreased expression of PDIA6 mRNA
CTD
PMID:18172885
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
Carboplatin results in increased expression of PMAIP1 protein
CTD
PMID:20802529
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Prkd2
protein kinase D2
affects response to substance
ISO
PRKD2 protein affects the susceptibility to Carboplatin
CTD
PMID:37951334
NCBI chr 1:77,513,625...77,542,386
Ensembl chr 1:77,513,986...77,542,376
G
Psmb2
proteasome 20S subunit beta 2
increases expression
EXP
Carboplatin results in increased expression of PSMB2 mRNA
CTD
PMID:18172885
NCBI chr 5:138,970,564...139,002,715
Ensembl chr 5:138,970,533...139,021,137
G
Psmb4
proteasome 20S subunit beta 4
decreases expression
EXP
Carboplatin results in decreased expression of PSMB4 mRNA
CTD
PMID:18172885
NCBI chr 2:182,442,757...182,445,532
Ensembl chr 2:182,442,756...182,445,746
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases response to substance multiple interactions
ISO
PTGS2 protein results in decreased susceptibility to Carboplatin wortmannin inhibits the reaction [PTGS2 protein results in decreased susceptibility to Carboplatin]
CTD
PMID:18089846
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rab10
RAB10, member RAS oncogene family
decreases expression
EXP
Carboplatin results in decreased expression of RAB10 mRNA
CTD
PMID:18172885
NCBI chr 6:26,267,081...26,319,739
Ensembl chr 6:26,266,859...26,320,193
G
Rbm17
RNA binding motif protein 17
decreases response to substance
ISO
RBM17 protein results in decreased susceptibility to Carboplatin
CTD
PMID:16061639
NCBI chr17:66,937,140...66,954,034
Ensembl chr17:66,937,140...66,954,014
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Carboplatin results in decreased localization of and results in decreased activity of RELA protein; Carboplatin results in increased activity of [NFKB1 protein binds to RELA protein]; NFKBIA gene mutant form inhibits the reaction [Carboplatin results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:12675310 PMID:15120608
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Scd2
stearoyl-Coenzyme A desaturase 2
decreases expression
EXP
Carboplatin results in decreased expression of SCD2 mRNA
CTD
PMID:18172885
NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232
G
Sik1
salt-inducible kinase 1
increases response to substance
ISO
SIK1 results in increased susceptibility to Carboplatin
CTD
PMID:21755009
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Slc31a1
solute carrier family 31 member 1
decreases response to substance multiple interactions increases import increases uptake increases response to substance
ISO EXP
SLC31A1 gene mutant form results in decreased susceptibility to Carboplatin [Penicillamine results in increased expression of SLC31A1 mRNA] which results in increased susceptibility to Carboplatin; [tetrathiomolybdate results in increased expression of SLC31A1 mRNA] which results in increased susceptibility to Carboplatin; [Trientine results in increased expression of SLC31A1 mRNA] which results in increased susceptibility to Carboplatin SLC31A1 protein results in increased import of Carboplatin SLC31A1 protein results in increased uptake of Carboplatin SLC31A1 protein results in increased susceptibility to Carboplatin
CTD
PMID:15634647 PMID:16847145 PMID:19509135 PMID:22914438 PMID:23123662
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc31a2
solute carrier family 31 member 2
decreases uptake
ISO
SLC31A2 protein results in decreased uptake of Carboplatin
CTD
PMID:19509135
NCBI chr 5:75,738,008...75,748,542
Ensembl chr 5:75,738,024...75,748,542
G
Smo
smoothened, frizzled class receptor
increases expression
ISO
Carboplatin results in increased expression of SMO mRNA
CTD
PMID:25605917
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Sod1
superoxide dismutase 1
multiple interactions decreases expression
EXP
Carboplatin results in decreased expression of and results in decreased activity of SOD1 protein Carboplatin results in decreased expression of SOD1 protein
CTD
PMID:15109710 PMID:15225673
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions decreases expression
EXP
Carboplatin results in increased expression of and results in increased activity of SOD2 protein Carboplatin results in decreased expression of SOD2 protein
CTD
PMID:15109710 PMID:15225673
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox2
SRY-box transcription factor 2
increases expression
ISO
Carboplatin results in increased expression of SOX2 mRNA
CTD
PMID:25605917
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Stat6
signal transducer and activator of transcription 6
multiple interactions
ISO
STAT6 gene mutant form inhibits the reaction [Carboplatin results in decreased expression of PDCD1LG2]
CTD
PMID:21765211
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stk39
serine threonine kinase 39
decreases expression
EXP
Carboplatin results in decreased expression of STK39 mRNA
CTD
PMID:18172885
NCBI chr 3:52,913,583...53,179,060
Ensembl chr 3:52,913,585...53,179,060
G
Stx2
syntaxin 2
increases response to substance
ISO
STX2 protein results in increased susceptibility to Carboplatin
CTD
PMID:24039787
NCBI chr12:27,678,744...27,714,751
Ensembl chr12:27,689,819...27,714,751
G
Tfap2a
transcription factor AP-2 alpha
increases response to substance
ISO
TFAP2A protein results in increased susceptibility to Carboplatin
CTD
PMID:16204029
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tnf
tumor necrosis factor
multiple interactions
EXP
[Carboplatin co-treated with Carnitine deficiency] results in increased expression of TNF protein
CTD
PMID:18852009
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Top2a
DNA topoisomerase II alpha
multiple interactions
ISO
TOP2A results in decreased susceptibility to [Carboplatin co-treated with Etoposide co-treated with Ifosfamide]
CTD
PMID:11325482
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tp53
tumor protein p53
increases expression multiple interactions
ISO
Carboplatin results in increased expression of TP53 mRNA; Carboplatin results in increased expression of TP53 protein [Carboplatin co-treated with Gallic Acid] results in increased expression of TP53 protein; [Gallic Acid co-treated with Carboplatin] results in increased expression of TP53 mRNA; [Paclitaxel co-treated with Carboplatin co-treated with Gallic Acid] results in increased expression of TP53 mRNA; [Paclitaxel co-treated with Carboplatin co-treated with Gallic Acid] results in increased expression of TP53 protein; [Paclitaxel co-treated with Carboplatin] results in increased expression of TP53 mRNA; [Paclitaxel co-treated with Carboplatin] results in increased expression of TP53 protein
CTD
PMID:9664115 PMID:15131059 PMID:33002289
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tyms
thymidylate synthetase
multiple interactions
ISO
PCNA mRNA affects the reaction [TYMS mRNA affects the susceptibility to Carboplatin]
CTD
PMID:16685392
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
decreases expression
EXP
Carboplatin results in decreased expression of UGT1A6 mRNA
CTD
PMID:18172885
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Vim
vimentin
decreases expression
EXP
Carboplatin results in decreased expression of VIM mRNA
CTD
PMID:18172885
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Xdh
xanthine dehydrogenase
affects activity
EXP
Carboplatin affects the activity of XDH protein
CTD
PMID:15225673
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
decreases response to substance
ISO
XPC results in decreased susceptibility to Carboplatin
CTD
PMID:19372135
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
G
Zfp36l1
zinc finger protein 36, C3H type-like 1
decreases expression
EXP
Carboplatin results in decreased expression of ZFP36L1 mRNA
CTD
PMID:18172885
NCBI chr 6:98,930,705...98,935,748
Ensembl chr 6:98,930,718...98,935,748
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
affects binding
EXP
Chromoglycate binds to Nme2 protein
RGD
PMID:20082612
RGD:4107023
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
G
Abcc4
ATP binding cassette subfamily C member 4
multiple interactions
EXP
[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] affects the expression of ABCC4 protein; Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of MRP4 protein]
CTD
PMID:35114312 PMID:36464070
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcg2
ATP binding cassette subfamily G member 2
increases expression multiple interactions
ISO EXP
Cromolyn Sodium results in increased expression of ABCG2 protein Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of ABCG2 protein]
CTD
PMID:36464070
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of ACTA2 protein]
CTD
PMID:35114312
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression
ISO
Cromolyn Sodium results in increased expression of ADIPOQ protein
CTD
PMID:23784744
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adora3
adenosine A3 receptor
decreases activity
EXP
Cromolyn Sodium results in decreased activity of ADORA3 protein
CTD
PMID:15641640
NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357
G
Agt
angiotensinogen
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [[Probenecid co-treated with adefovir] results in increased expression of AGT protein]; Cromolyn Sodium inhibits the reaction [Purines analog results in increased secretion of AGT protein]
CTD
PMID:35114312 PMID:36464070
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of AKT1 protein]
CTD
PMID:28732690
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein]
CTD
PMID:28732690
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Calca
calcitonin-related polypeptide alpha
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [Paclitaxel results in increased expression of CALCA protein]
CTD
PMID:15033348
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Cst3
cystatin C
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of CST3 protein]
CTD
PMID:35114312
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Ctnnb1
catenin beta 1
multiple interactions
EXP
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein]
CTD
PMID:28732690
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctsd
cathepsin D
multiple interactions
ISO
[pristane co-treated with Cromolyn Sodium] results in increased expression of CTSD protein
CTD
PMID:8812242
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
Cromolyn Sodium results in decreased expression of DNMT1 mRNA; Cromolyn Sodium results in decreased expression of DNMT1 protein
CTD
PMID:35961540
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Gpr35
G protein-coupled receptor 35
affects localization multiple interactions
ISO EXP
Cromolyn Sodium affects the localization of GPR35 protein 2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid inhibits the reaction [Cromolyn Sodium affects the localization of GPR35 protein]; 2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid inhibits the reaction [Cromolyn Sodium binds to and results in increased activity of GPR35 protein]; Cromolyn Sodium binds to and results in increased activity of GPR35 protein; methyl 5-((tert-butylcarbamothioylhydrazinylidene)methyl)-1-(2,4-difluorophenyl)pyrazole-4-carboxylate inhibits the reaction [Cromolyn Sodium affects the localization of GPR35 protein]; methyl 5-((tert-butylcarbamothioylhydrazinylidene)methyl)-1-(2,4-difluorophenyl)pyrazole-4-carboxylate inhibits the reaction [Cromolyn Sodium binds to and results in increased activity of GPR35 protein]
CTD
PMID:20919992 PMID:22967846
NCBI chr 9:93,527,165...93,539,573
Ensembl chr 9:93,527,127...93,539,299
G
Gpx1
glutathione peroxidase 1
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of GPX1 protein]
CTD
PMID:36464070
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions
EXP
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of GSK3B protein]
CTD
PMID:28732690
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Ins1
insulin 1
increases expression
ISO
Cromolyn Sodium results in increased expression of INS1 protein
CTD
PMID:23784744
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
Cromolyn Sodium results in decreased phosphorylation of MAPK1 protein
CTD
PMID:35961540
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation
EXP ISO
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of MAPK3 protein] Cromolyn Sodium results in decreased phosphorylation of MAPK3 protein
CTD
PMID:28732690 PMID:35961540
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mettl3
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit
decreases expression
ISO
Cromolyn Sodium results in decreased expression of METTL3 mRNA; Cromolyn Sodium results in decreased expression of METTL3 protein
CTD
PMID:35961540
NCBI chr15:25,002,505...25,014,097
Ensembl chr15:25,003,172...25,014,041
G
Mmp2
matrix metallopeptidase 2
multiple interactions increases expression
EXP
Cromolyn Sodium inhibits the reaction [Norepinephrine results in increased expression of MMP2 mRNA] Cromolyn Sodium results in increased expression of MMP2 mRNA
CTD
PMID:14577597
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Pomc
proopiomelanocortin
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [POMC results in increased secretion of Corticosterone]
CTD
PMID:1659878
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of RELA protein]
CTD
PMID:28732690
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ren
renin
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [Purines analog results in increased secretion of REN protein]
CTD
PMID:36464070
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Retn
resistin
decreases expression
ISO
Cromolyn Sodium results in decreased expression of RETN protein
CTD
PMID:23784744
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
G
Slc22a12
solute carrier family 22 member 12
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of SLC22A12 protein]
CTD
PMID:36464070
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
EXP
[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] affects the expression of SLC22A6 protein; Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of SLC22A6 protein]
CTD
PMID:35114312 PMID:36464070
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
multiple interactions
EXP
[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] results in increased expression of SLC22A8 protein; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in decreased expression of SLC22A8 protein]; Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of SLC22A8 protein]
CTD
PMID:35114312 PMID:36464070
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Sod1
superoxide dismutase 1
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of SOD1 protein]
CTD
PMID:36464070
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Tac1
tachykinin, precursor 1
multiple interactions
EXP
Cromolyn Sodium inhibits the reaction [Paclitaxel results in increased expression of TAC1 protein]
CTD
PMID:15033348
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tgfb1
transforming growth factor, beta 1
multiple interactions increases secretion
ISO EXP
[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Cromolyn Sodium] results in increased secretion of TGFB1 protein; [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with masitinib co-treated with Cromolyn Sodium] results in increased secretion of TGFB1 protein; [masitinib co-treated with Cromolyn Sodium] results in increased secretion of TGFB1 protein Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of TGFB1 protein] Cromolyn Sodium results in increased secretion of TGFB1 protein
CTD
PMID:35007524 PMID:35114312
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Cromolyn Sodium inhibits the reaction [[hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride]
CTD
PMID:22414385
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
increases localization
EXP
Glutamate increases localization of Gria1 protein within medium spiny neurons
RGD
PMID:15255976
RGD:405820209
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Ackr3
atypical chemokine receptor 3
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of ACKR3 mRNA
CTD
PMID:19192274
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Adora2a
adenosine A2a receptor
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of ADORA2A mRNA
CTD
PMID:19192274
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Amigo2
adhesion molecule with Ig like domain 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of AMIGO2 mRNA
CTD
PMID:19192274
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
G
Antxr1
ANTXR cell adhesion molecule 1
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of ANTXR1 mRNA
CTD
PMID:19192274
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
G
Aox1
aldehyde oxidase 1
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of AOX1 mRNA
CTD
PMID:19192274
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Bcl2a1
BCL2-related protein A1
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of BCL2A1 mRNA
CTD
PMID:19192274
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of BST2 mRNA
CTD
PMID:19192274
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Ccl20
C-C motif chemokine ligand 20
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of CCL20 mRNA; Gold Sodium Thiomalate results in decreased expression of CCL20 protein
CTD
PMID:19192274
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccn1
cellular communication network factor 1
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of CCN1 mRNA
CTD
PMID:19192274
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn5
cellular communication network factor 5
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of CCN5 mRNA
CTD
PMID:19192274
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
G
Cd28
Cd28 molecule
multiple interactions affects response to substance
ISO
CD28 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein] CD28 protein affects the susceptibility to Gold Sodium Thiomalate
CTD
PMID:19077085
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased activity of CHUK protein]
CTD
PMID:10820281
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
G
Clgn
calmegin
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of CLGN mRNA
CTD
PMID:19192274
NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of COL1A1 mRNA
CTD
PMID:19192274
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Colec12
collectin sub-family member 12
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of COLEC12 mRNA
CTD
PMID:19192274
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of CXCL1 mRNA
CTD
PMID:19192274
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of CXCL2 mRNA
CTD
PMID:19192274
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of CXCL1 mRNA
CTD
PMID:19192274
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of CXCR4 mRNA
CTD
PMID:19192274
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Ddx10
DEAD-box helicase 10
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of DDX10 mRNA
CTD
PMID:19192274
NCBI chr 8:53,488,656...53,643,373
Ensembl chr 8:53,488,656...53,643,373
G
Dio1
iodothyronine deiodinase 1
decreases activity
ISO
Gold Sodium Thiomalate results in decreased activity of DIO1 protein
CTD
PMID:34662569
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of EFEMP1 mRNA
CTD
PMID:19192274
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of ENPP2 mRNA
CTD
PMID:19192274
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Entpd3
ectonucleoside triphosphate diphosphohydrolase 3
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of ENTPD3 mRNA
CTD
PMID:19192274
NCBI chr 8:120,246,412...120,277,943
Ensembl chr 8:120,247,121...120,277,943
G
Fbl
fibrillarin
affects localization decreases activity multiple interactions
ISO
Gold Sodium Thiomalate affects the localization of FBL protein Gold Sodium Thiomalate results in decreased activity of FBL protein CD28 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IFNG protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL4 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL6 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]
CTD
PMID:10942594 PMID:19077085
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
G
Fbln1
fibulin 1
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of FBLN1 mRNA
CTD
PMID:19192274
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fgf7
fibroblast growth factor 7
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of FGF7 mRNA
CTD
PMID:19192274
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Gbp1
guanylate binding protein 1
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of GBP1 mRNA
CTD
PMID:19192274
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gpm6b
glycoprotein m6b
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of GPM6B mRNA
CTD
PMID:19192274
NCBI chr X:28,057,788...28,204,409
Ensembl chr X:28,059,450...28,204,211
G
Gsdme
gasdermin E
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of GSDME mRNA
CTD
PMID:19192274
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
G
Herc6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of HERC6 mRNA
CTD
PMID:19192274
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
G
Hilpda
hypoxia inducible lipid droplet-associated
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of HILPDA mRNA
CTD
PMID:19192274
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of HSD11B1 mRNA
CTD
PMID:19192274
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Ifi27
interferon, alpha-inducible protein 27
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IFI27 mRNA
CTD
PMID:19192274
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Ifi35
interferon-induced protein 35
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IFI35 mRNA
CTD
PMID:19192274
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifi44
interferon-induced protein 44
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IFI44 mRNA
CTD
PMID:19192274
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IFI44L mRNA
CTD
PMID:19192274
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifih1
interferon induced with helicase C domain 1
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IFIH1 mRNA
CTD
PMID:19192274
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IFIT3 mRNA
CTD
PMID:19192274
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifng
interferon gamma
multiple interactions affects response to substance
ISO
IFNG protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein] IFNG protein affects the susceptibility to Gold Sodium Thiomalate
CTD
PMID:19077085
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased activity of IKBKB protein]
CTD
PMID:10820281
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
multiple interactions
ISO
[Gold Sodium Thiomalate co-treated with mercury nitrate analog] results in increased expression of IL10 protein
CTD
PMID:11824965
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Gold Sodium Thiomalate inhibits the reaction [IL1B protein results in increased expression of PTGES]
CTD
PMID:16393772 PMID:25314295
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IL1RN mRNA
CTD
PMID:19192274
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il23a
interleukin 23 subunit alpha
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IL23A mRNA
CTD
PMID:19192274
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il4
interleukin 4
multiple interactions affects response to substance
ISO
IL4 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein] IL4 protein affects the susceptibility to Gold Sodium Thiomalate
CTD
PMID:19077085
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
multiple interactions decreases expression affects response to substance
ISO
[Gold Sodium Thiomalate co-treated with mercury nitrate analog] results in increased expression of IL6 protein Gold Sodium Thiomalate results in decreased expression of IL6 mRNA; Gold Sodium Thiomalate results in decreased expression of IL6 protein IL6 protein affects the susceptibility to Gold Sodium Thiomalate IL6 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]
CTD
PMID:11824965 PMID:19077085 PMID:19192274
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf7
interferon regulatory factor 7
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of IRF7 mRNA
CTD
PMID:19192274
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Isg15
ISG15 ubiquitin-like modifier
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of ISG15 mRNA
CTD
PMID:19192274
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Isg20
interferon stimulated exonuclease gene 20
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of ISG20 mRNA
CTD
PMID:19192274
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Lamb3
laminin subunit beta 3
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of LAMB3 mRNA
CTD
PMID:19192274
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
G
Lxn
latexin
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of LXN mRNA
CTD
PMID:19192274
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
G
Ly6e
lymphocyte antigen 6 family member E
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of LY6E mRNA
CTD
PMID:19192274
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
G
Marcks
myristoylated alanine rich protein kinase C substrate
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of MARCKS mRNA
CTD
PMID:19192274
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
G
Met
MET proto-oncogene, receptor tyrosine kinase
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of MET mRNA
CTD
PMID:19192274
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mir99b
microRNA 99b
multiple interactions
ISO
Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased expression of MIR99B mRNA]
CTD
PMID:33109608
NCBI chr 1:58,677,015...58,677,084
Ensembl chr 1:58,677,011...58,677,090
G
Mmp10
matrix metallopeptidase 10
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of MMP10 mRNA
CTD
PMID:19192274
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mx1
MX dynamin like GTPase 1
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of MX1 mRNA
CTD
PMID:19192274
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Ndufa4l2
NDUFA4, mitochondrial complex associated like 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of NDUFA4L2 mRNA
CTD
PMID:19192274
NCBI chr 7:63,351,021...63,359,010
Ensembl chr 7:63,356,883...63,359,010
G
Nmb
neuromedin B
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of NMB mRNA
CTD
PMID:19192274
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]
CTD
PMID:16393772
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of NR4A3 mRNA
CTD
PMID:19192274
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
G
Oas1a
2'-5' oligoadenylate synthetase 1A
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of OAS1 mRNA
CTD
PMID:19192274
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
G
Oasl
2'-5'-oligoadenylate synthetase-like
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of OASL mRNA
CTD
PMID:19192274
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
G
Olfml2b
olfactomedin-like 2B
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of OLFML2B mRNA
CTD
PMID:19192274
NCBI chr13:82,869,414...82,906,607
Ensembl chr13:82,869,433...82,906,607
G
Phgdh
phosphoglycerate dehydrogenase
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of PHGDH mRNA
CTD
PMID:19192274
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Plpp3
phospholipid phosphatase 3
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of PLPP3 mRNA
CTD
PMID:19192274
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Ppp4r2
protein phosphatase 4, regulatory subunit 2
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of PPP4R2 mRNA
CTD
PMID:19192274
NCBI chr 4:133,454,555...133,495,486
Ensembl chr 4:133,454,555...133,495,486
G
Ptges
prostaglandin E synthase
multiple interactions
ISO
Gold Sodium Thiomalate inhibits the reaction [IL1B protein results in increased expression of PTGES]
CTD
PMID:25314295
NCBI chr 3:14,177,892...14,189,236
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of PTGS2 mRNA
CTD
PMID:19192274
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rarres1
retinoic acid receptor responder 1
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of RARRES1 mRNA
CTD
PMID:19192274
NCBI chr 2:151,749,715...151,783,975
Ensembl chr 2:151,749,715...151,783,978
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]
CTD
PMID:33109608
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rgs4
regulator of G-protein signaling 4
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of RGS4 mRNA
CTD
PMID:19192274
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rig1
RNA sensor RIG-1
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of RIGI mRNA
CTD
PMID:19192274
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
G
Ripk2
receptor-interacting serine-threonine kinase 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of RIPK2 mRNA
CTD
PMID:19192274
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
Rnf19b
ring finger protein 19B
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of RNF19B mRNA
CTD
PMID:19192274
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
G
Rsad2
radical S-adenosyl methionine domain containing 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of RSAD2 mRNA
CTD
PMID:19192274
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of SLC7A11 mRNA
CTD
PMID:19192274
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Sms
spermine synthase
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of SMS mRNA
CTD
PMID:19192274
NCBI chr X:37,516,949...37,572,657
Ensembl chr X:37,516,931...37,570,822 Ensembl chr 3:37,516,931...37,570,822
G
Sod2
superoxide dismutase 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of SOD2 mRNA
CTD
PMID:19192274
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Spon1
spondin 1
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of SPON1 mRNA
CTD
PMID:19192274
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Stat1
signal transducer and activator of transcription 1
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of STAT1 mRNA
CTD
PMID:19192274
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Sts
steroid sulfatase
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of STS mRNA
CTD
PMID:19192274
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
G
Thbs1
thrombospondin 1
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of THBS1 mRNA
CTD
PMID:19192274
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thbs2
thrombospondin 2
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of THBS2 mRNA
CTD
PMID:19192274
NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789
G
Tlr2
toll-like receptor 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of TLR2 mRNA
CTD
PMID:19192274
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tnfaip2
TNF alpha induced protein 2
decreases expression
ISO
Gold Sodium Thiomalate results in decreased expression of TNFAIP2 mRNA
CTD
PMID:19192274
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
G
Txnip
thioredoxin interacting protein
increases expression
ISO
Gold Sodium Thiomalate results in increased expression of TXNIP mRNA
CTD
PMID:19192274
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnrd1
thioredoxin reductase 1
multiple interactions decreases activity
ISO EXP
Gold Sodium Thiomalate inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid] Gold Sodium Thiomalate results in decreased activity of TXNRD1 protein
CTD
PMID:16510263 PMID:17229725
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
decreases activity
EXP
Gold Sodium Thiomalate results in decreased activity of TXNRD2 protein
CTD
PMID:15458826
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all